Nicole M. Lewandowski, Ph.D.

Affiliations: 
2008 Columbia University, New York, NY 
Area:
Brain Imaging, Neurobiology of Disease, Neurobiology of Learning and Memory, Neural Degeneration and Repair
Google:
"Nicole Lewandowski"
Mean distance: 42746.4
 

Parents

Sign in to add mentor
Scott A. Small grad student 2008 Columbia
 (Imaging-guided microarray identifies molecular markers in schizophrenia and Parkinson's disease.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lander SS, Khan U, Lewandowski N, et al. (2018) Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. Schizophrenia Bulletin
Lander SS, Chakraborti D, Donner R, et al. (2017) 216. Glutamate Dehydrogenase-Deficient Mice: A Novel Mouse Model of Schizophrenia-Like Phenotypes Schizophrenia Bulletin. 43: S109-S110
Lewandowski NM, Bordelon Y, Brickman AM, et al. (2013) Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93
Lewandowski NM, Bordelon Y, Brickman AM, et al. (2013) Corrigendum to "Regional vulnerability in Huntington's disease: FMRI-guided molecular analysis in patients and a mouse model of disease" [Neurobiol Dis 52 (2013) 84-93] Neurobiology of Disease. 54: 115
Lewandowski NM, Ju S, Verbitsky M, et al. (2010) Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 16970-5
Schobel SA, Lewandowski NM, Corcoran CM, et al. (2009) Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry. 66: 938-46
Gaisler-Salomon I, Miller GM, Chuhma N, et al. (2009) Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2305-22
Chen YJ, Johnson MA, Lieberman MD, et al. (2008) Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6872-83
Lewandowski NM, Small SA. (2005) Brain microarray: finding needles in molecular haystacks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10341-6
See more...